|
CY2018030I2
(en)
|
|
PHARMACEUTICAL FORM 514
|
|
SMT201700008B
(en)
|
|
PHARMACEUTICAL COMPOSITION
|
|
SMT201500232B
(en)
|
|
Device for drug administration
|
|
SMT201700095B
(en)
|
|
COMPOSITION PHARMACEUTICAL PER INALAZIONE
|
|
BRPI1012004A2
(en)
|
|
"pharmaceutical form"
|
|
DK3246018T3
(en)
|
|
PHARMACEUTICAL COMPOSITION
|
|
DK3097925T3
(en)
|
|
PHARMACEUTICAL COMPOSITION
|
|
SMT201400069B
(en)
|
|
Pharmaceutical formulation
|
|
FR2957244B1
(en)
|
|
ARTHRODESE IMPLANT
|
|
BRPI1004940A2
(en)
|
|
pharmaceutical composition
|
|
IT1394860B1
(en)
|
|
PHARMACEUTICAL COMPOUNDS
|
|
GT201200303A
(en)
|
|
PHARMACEUTICAL FORMULATIONS
|
|
BRPI1015939A2
(en)
|
|
pharmaceutical composition
|
|
EE201300005A
(en)
|
|
Pharmaceutical composition
|
|
DK2652652T3
(en)
|
|
MEDICINE ADMINISTRATION
|
|
DK2627345T3
(en)
|
|
TREATMENT FOR DISEASE DISEASES
|
|
CO6940426A2
(en)
|
|
Pharmaceutical formulations
|
|
BRPI0922653A2
(en)
|
|
pharmaceutical preparation
|
|
DK2542224T3
(en)
|
|
ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANETEXILATE
|
|
IL230441A0
(en)
|
|
Diagnosis of alzheimer's disease
|
|
SMT201500005B
(en)
|
|
Inhalable pharmaceutical composition
|
|
BR112013008074A2
(en)
|
|
pharmaceutical combinations
|
|
IT1393930B1
(en)
|
|
PHARMACEUTICAL COMPOUNDS
|
|
BR112012003149A2
(en)
|
|
pharmaceutical composition
|
|
BR112012029461A2
(en)
|
|
solifenacin-containing pharmaceutical composition
|